High expression of soluble CD155 in estrogen receptor-negative breast cancer.

Breast Cancer : the Journal of the Japanese Breast Cancer Society
Akiko Iguchi-ManakaKazuko Shibuya

Abstract

The poliovirus receptor (CD155) is expressed ubiquitously at low levels on both hematopoietic and nonhematopoietic cells, but its expression is upregulated in various tumor cells. An activating receptor DNAM-1 expressed on cytotoxic T lymphocytes (CTLs) and natural killer (NK) cells binds to CD155 and mediates the cytotoxic activity of CTLs and NK cells against tumors. Unlike mouse tissues, human tissues express a soluble form of CD155 (sCD155), which is a splicing isoform of CD155 lacking the transmembrane region. We previously reported that the serum levels of sCD155 were higher in lung, gastrointestinal, breast, and gynecologic cancer patients than in healthy donors. Here, we focus on breast cancer patients. To analyze the association between serum level of sCD155 and clinicopathological parameters of breast cancer, we quantified sCD155 in the sera of 153 breast cancer patients by sandwich ELISA. sCD155 levels in the sera of breast cancer patients were positively correlated with patient age, disease stage, and invasive tumor size. Moreover, they were higher in patients with estrogen receptor (ER)-negative cancers than in those with ER-positive tumors, and higher in those with Ki-67-high cancers than in those with Ki-67-low c...Continue Reading

References

Aug 30, 2000·Nature·C M PerouD Botstein
Sep 13, 2001·Proceedings of the National Academy of Sciences of the United States of America·T SørlieA L Børresen-Dale
Jul 9, 2003·The Journal of Biological Chemistry·Hiroshi KojimaAkira Shibuya
Aug 13, 2003·The Journal of Experimental Medicine·Cristina BottinoAlessandro Moretta
Aug 15, 2003·Proceedings of the National Academy of Sciences of the United States of America·Christos SotiriouEdison T Liu
Aug 29, 2003·Biochemical and Biophysical Research Communications·Béatrice BauryMarc G Denis
Mar 23, 2004·Annual Review of Immunology·Gavin P DunnRobert D Schreiber
Mar 23, 2004·The Journal of Immunology : Official Journal of the American Association of Immunologists·Anja FuchsMarco Colonna
Mar 9, 2005·Biochemical and Biophysical Research Communications·Satoko Tahara-HanaokaAkira Shibuya
Mar 18, 2005·Annual Review of Immunology·Lewis L Lanier
Jun 28, 2005·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M ColozzaM J Piccart
Jun 8, 2006·JAMA : the Journal of the American Medical Association·Lisa A CareyRobert C Millikan
Oct 26, 2006·Nature Reviews. Immunology·Gavin P DunnRobert D Schreiber
May 4, 2007·The Journal of Clinical Investigation·Jeremy B Swann, Mark J Smyth
Nov 26, 2008·The Journal of Experimental Medicine·Akiko Iguchi-ManakaAkira Shibuya
Apr 8, 2009·The Journal of Clinical Investigation·Tadepally LakshmikanthFrancesco Colucci
Feb 16, 2010·The Lancet Oncology·Rinat YerushalmiKaren A Gelmon
Jun 29, 2011·Annals of Oncology : Official Journal of the European Society for Medical Oncology·A GoldhirschUNKNOWN Panel members
Apr 7, 2016·PloS One·Akiko Iguchi-ManakaKazuko Shibuya

❮ Previous
Next ❯

Citations

Aug 27, 2021·Journal of Experimental & Clinical Cancer Research : CR·Baokang WuYu Tian

❮ Previous
Next ❯

Methods Mentioned

BETA
ELISA
biopsy

Software Mentioned

GraphPad Prism

Related Concepts

Related Feeds

Cancer Biology: Molecular Imaging

Molecular imaging enables noninvasive imaging of key molecules that are crucial to tumor biology. Discover the latest research in molecular imaging in cancer biology in this feed.